In this randomized, double-blind study of 60 patients, we have assessed the analgesic efficacy of extradural bupivacaine and extradural fentanyl, either alone or in combination, after Caesarean section. Patients received 0.1 % bupivacaine (group B), fentanyl 4 g ml 91 (group F) or 0.05 % bupivacaine combined with fentanyl 2 g ml 91 (group BF) by patient-controlled extradural analgesia (PCEA). Adding fentanyl to bupivacaine reduced the dose of bupivacaine by up to 68 %, improved analgesia at rest and decreased PCEA use. Motor and sensory block were decreased, but there was more pruritus. Overall patient satisfaction was increased. Adding bupivacaine to fentanyl reduced the dose of fentanyl by up to 57 % without altering pain scores or PCEA use. Sensory block increased but pruritus did not decrease. Bupivacaine 0.05 % produced clinically significant leg weakness in three patients. Overall patient satisfaction was not altered. There was a significant additive analgesic effect between 0.05 % bupivacaine and fentanyl but no clinical benefit was demonstrated from using the combination compared with fentanyl alone for this group of postoperative patients. (Br.
Extradural fentanyl produces effective postoperative analgesia with a low incidence of serious side effects. Extradural bupivacaine can produce excellent analgesia at the expense of dose-dependent side effects from sensory, motor and sympathetic block. Laboratory work has demonstrated a supra-additive analgesic effect between intrathecal local anaesthetics and opioids [1] . Despite this finding it is unclear if it is clinically beneficial to add bupivacaine to fentanyl for postoperative extradural analgesia. Some studies have shown no benefits from this practice [2] [3] [4] [5] , whereas others have demonstrated either reductions in fentanyl dose, improved analgesia, or both [6] [7] [8] [9] [10] .
The aims of this study were to assess the effects of combining extradural bupivacaine with extradural fentanyl and to compare the two drugs for analgesia after Caesarean section. Half strength solutions were used for the combination group. This, in conjunction with patient-controlled extradural analgesia (PCEA), was to try to minimize the dose of each drug used in combination, while at the same time maintaining analgesic efficacy. Analgesic dose requirements, visual analogue pain scores, PCEA use, side effects and overall patient satisfaction were examined over the first 24 h after operation.
Patients and methods
The study was double-blind and approved by the local Hospital Ethics Committee. After obtaining informed consent, we studied 60 ASA I-II patients undergoing morning elective Caesarean section under extradural analgesia.
In the anaesthetic room, before insertion of the extradural catheter, baseline arterial pressure, heart rate and ventilatory frequency were recorded with the patient lying in the left lateral position. In all patients an extradural catheter was inserted at L2-3 or an adjacent space. Neural block was produced using 0.5 % bupivacaine. After an initial 3-ml test dose the subsequent 10 ml contained fentanyl 50 g. Thereafter sufficient bupivacaine was administered to achieve a block to T4-T6. Further intraoperative analgesia, if required, was provided by i.v. fentanyl or alfentanil.
From the end of operation patients were free to use a PCEA device which was allocated randomly to deliver either 0.1 % bupivacaine (group B), fentanyl 4 g ml 91 (group F) or 0.05 % bupivacaine combined with fentanyl 2 g ml 91 (group BF). The PCEA device was programmed to allow a 5-ml bolus with a 10-min lockout interval. Patient grouping was decided by opening a blank envelope from a set of 60 shuffled envelopes containing either the code for group B (n : 20), F (n : 20) or BF (n : 20). The investigator who set up the PCEA was not involved with subsequent patient management or assessment. Patients, nursing and medical staff were unaware of patient grouping.
The study lasted for 24 h from the end of operation. Patients were kept in a recovery area for 4 h and then transferred to the postnatal ward. Postoperative analgesia was provided solely by PCEA. All patients were educated in the use of PCEA and informed that they had to wait for 10 min before the next dose would be available. If analgesia was judged to be inadequate by the patient herself, nursing or medical staff, then the study was stopped at that point. The extradural catheter was left in position for assessment by an anaesthetist and the patient was given alternative analgesia. Data were analysed provided the catheter had not become displaced.
Volumes of analgesic solution self-administered were recorded at 0.5, 4, 8, 12 and 24 h. At the same times visual analogue scores for pain (VAS) at rest and on coughing (100-mm scale; 0 : no pain, 100 mm : worst pain imaginable), and also sedation scores were recorded. The presence or absence of nausea, vomiting and pruritus was recorded for the time periods 0-0.5, 0.5-4, 4-8, 8-12 and 12-24 h. Pruritus was graded as mild, moderate or severe. A verbal rating score (VRS) for overall satisfaction (0 : excellent, 1 : adequate, 2 : fair, 3 : poor) was recorded for those patients completing 24 h. VRS : 3 if the patient stopped early because of side effects or inadequate analgesia, despite good catheter position. Arterial pressure and ventilatory frequency were measured every 1-2 h and more frequently if systolic arterial pressure (AP) was less than 100 mm Hg or ventilatory frequency less than 10 bpm.
Between 20 and 24 h, patients were assessed on one occasion by an anaesthetist for maximum sensory block, motor block, postural hypotension (supine, sitting and standing AP using an automated NIBP device) and ability to walk unaided. Maximum sensory block to ethyl chloride spray was assessed on a four-point scale: 0 : no area of reduced sensation, 1 : area of reduced sensation but still cold, 2 : area of reduced sensation but not cold and 3 : area of complete absence of sensation. Motor block was assessed on a four-point scale: 0 : no weakness detected, 1 : able to straight leg raise, but power reduced, 2 : unable to straight leg raise and 3 : unable to raise knee off bed. Ability to walk was assessed only if there was no leg weakness or postural hypotension and the patient felt sufficiently pain free.
A computer package (SPSS) was used for statistical analysis. Results were compared using MannWhitney and Kruskal-Wallis tests, with P : 0.05 taken as significant.
Results
We studied 60 patients, 20 in each group. Four patients (two in group B, one in group F and one in group BF) were subsequently excluded because the extradural catheter became dislodged in the postoperative period. Groups were matched for age, height, weight and operative analgesia (table 1) .
Eight additional patients (seven in group B, one in group F) stopped before completing 24 h. Five stopped in group B because of inadequate analgesia despite good catheter position (one at 4-8 h and four at 12-24 h), compared with none in groups F or BF. Another two patients in group B stopped at 12-24 h because they did not like the feeling of numbness in their legs. One patient in group F stopped at 12-24 h because of a malfunction in the PCEA device. Data from these patients were included up to the assessment time before premature cessation of the study.
Pain scores at rest are shown in figure 1 . At 12 h, group B had higher scores at rest compared with both groups F and BF: group B median 34 (interquartile range (IQR) 11-47) mm, group F 10 (8-31) mm (P : 0.05), group BF 12 (4-21) mm (P : 0.05). Pain scores on coughing are shown in figure 2. There was no significant difference between the three groups at any of the assessment times. Pain scores were no lower at rest than on coughing in group B, whereas they were lower at rest in both groups F and BF. Mean pain scores at 8 and 12 h at rest compared with on coughing were as follows: group B 27 (13-33) mm at rest to 24 (10-51) mm on coughing; group F 17 (8-25) mm at rest to 29 (20-35) mm on coughing (P : 0.01); group BF 17 (7-20) mm at rest to 26 (16-47) mm on coughing (P : 0.005).
Volumes of analgesic solution self-administered are shown in figure 3 . Group B had significantly greater PCEA use than both groups F and BF. There was no difference between group F and group BF.
Doses of bupivacaine and fentanyl selfadministered are shown in table 2. Combining bupivacaine and fentanyl reduced significantly the doses of both drugs administered. For patients who completed 24 h, overall reductions in the doses of bupivacaine and fentanyl were 62 % and 53 %, respectively. The maximum reduction for bupivacaine (68 %) occurred at 8-12 h and for fentanyl (57 %) at 12-24 h.
The overall incidence of nausea or vomiting was low and there was no significant difference between groups (table 3). All sedation was mild (occasionally drowsy, easy to arouse) apart from one patient in group BF who had moderate sedation (frequently drowsy, easy to arouse). Pruritus was similar for groups F and BF and significantly more frequent than in group B.
Eleven patients in group B, 18 in group F and 19 in group BF remained in the study for the full 24 h. Testing for sensory block, motor block, postural hypotension and ability to walk unaided was performed at 20-24 h (table 3) .
Maximum sensory block was significantly greater for both groups B (0 : 10 %, 1 : 10 %, 2 : 40 %, 3 : 40 %) and BF (0 : 25 %, 1 : 25 %, 2 : 44 %, 3 : 6 %) than for group F (0 : 89 %, 1 : 11 %). Group B also had significantly greater sensory block than group BF. One of 11 patients in group B was not tested for sensory block.
Motor block was significantly greater for group B (0 : 27 %, 1 : 18 %, 2 : 45 %, 3 : 9 %) compared with group F (0 : 100 %) and group BF (0 : 84 %, 1 : 11 %, 2 : 5 %). The difference between groups F and BF was not significant (P : 0.08). The mean dose of bupivacaine administered in group BF at 12-24 h was 4.8 mg h 91 for those with leg weakness and 3.2 mg h 91 for those without. Postural hypotension was tested in three patients in group B, 18 in group F and 18 in group BF who were sufficiently free from pain or motor block. Patients were considered to have postural hypotension if they were unable to stand because of dizziness or had a systolic arterial pressure (AP) : 90 mm Hg on attempting to sit or stand. One of three patients in group F with postural hypotension had a recorded AP : 90 mm Hg compared with four of seven patients in group BF with postural hypotension. There was no significant difference between the groups.
A total of 82 % of patients in group B were unable to walk (11 % because of pain, 89 % motor block), 24 % in group F (25 % because of pain, 75 % postural hypotension) and 53 % in group BF (30 % because of motor block, 70 % postural hypotension). The difference between groups B and F was significant but group BF was not significantly different from group B (P : 0.12) or group F (P : 0.08). One of 18 patients in group F was not tested for mobility. Minimum postoperative arterial pressure was not significantly different between the three groups and hypotension (AP : 90 mm Hg) was not recorded for any patient other than during testing for postural hypotension. Minimum ventilatory frequency was not significantly different between groups and no patient had a recorded rate of less than 12 bpm.
Verbal rating scores for overall patient satisfaction were significantly poorer for group B (33 % excellent, 28 % adequate, 0 % fair, 39 % poor) compared with both group F (67 % excellent, 28 % adequate, 6 % fair, 0 % poor) (P : 0.05) and group BF (63 % excellent, 26 % adequate, 11 % fair, 0 % poor) (P : 0.05). There was no significant difference between groups F and BF.
Discussion
Intrathecal local anaesthetics and opioids have been shown to have a synergistic analgesic action in laboratory work [1] . Studies examining extradural analgesia, after abdominal aortic and orthopaedic surgery [7, 8] , have shown that combining bupivacaine and fentanyl can result in reductions in doses of the order of 20 % for each drug while maintaining or improving analgesia. Despite these findings several studies have failed to demonstrate any benefit from adding dilute bupivacaine to fentanyl [2] [3] [4] [5] . However, evidence increasingly shows that adding solutions of bupivacaine of 0.1 % or greater to fentanyl can either improve analgesia, reduce fentanyl requirements, or both [6] [7] [8] [9] [10] .
In this study we found a clear overall benefit from adding fentanyl to bupivacaine. It allowed a reduction in bupivacaine dose of up to 68 %, with improved analgesia for rest pain, decreased PCEA use and increased patient satisfaction. As a result of the reduced bupivacaine dose there was less motor and sensory block, but the addition of fentanyl led to an increase in predominantly mild pruritus.
Overall benefits from adding bupivacaine to fentanyl were less apparent. It allowed a reduction in the dose of fentanyl of up to 57 % without altering the low pain scores, PCEA use or the high level of patient satisfaction. However, the decreased dose of fentanyl did not reduce pruritus, whereas the addition of bupivacaine increased sensory block. Clinically significant leg weakness also occurred in 16 % of patients who received 0.05 % bupivacaine. Although the finding was not statistically significant (P : 0.08) this was probably a type II error as fentanyl by itself would not be expected to produce motor block. The mean dose of bupivacaine administered during the period that motor block was assessed was only 3.5 mg h 91 (4.8 mg h 91 for those with leg weakness). This dose was similar to that from two previous studies (approximately 4 mg h 91 ) which also found problems from bupivacaine-related side effects [10, 11] .
Our study also compared bupivacaine alone with fentanyl alone for postoperative analgesia. Bupivacaine produced a similar degree of analgesia on coughing to fentanyl but was less effective at relieving rest pain, even though PCEA use was greater. As a result of inadequate analgesia, 28 % of those receiving bupivacaine, compared with none receiving fentanyl, requested premature cessation of the study. Bupivacaine was also associated with a higher incidence of clinically significant side effects than fentanyl. Sensory block with bupivacaine resulted in two patients stopping early because they found the lack of sensation unpleasant and motor block reduced mobility on the first morning after operation. Of the side effects commonly associated with extradural opioids, there was a high incidence of mild pruritus with fentanyl, but no nausea or vomiting. More effective analgesia, combined with fewer side effects, produced greater patient satisfaction with fentanyl.
The difference in pain scores at rest between bupivacaine and the two fentanyl-containing groups did not occur until 12 h after operation. This may have been because of residual operative analgesia or tachyphylaxis. By 24 h there was again no significant difference. This was probably because of a reduction in the numbers of patients in group B, especially as the majority who stopped early did so because of inadequate analgesia.
At 12 h, when pain scores at rest were significantly lower for each fentanyl-containing group than for bupivacaine alone, pain scores on coughing were similar for all three groups. This suggests that when fentanyl-containing solutions inhibited somatic pain to a similar degree to bupivacaine alone, they were more effective at inhibiting visceral pain. In order to satisfactorily inhibit visceral pain, greater rostral spread of an analgesic solution would be required than to inhibit somatic pain. Lumbar extradural administration of fentanyl can result in detectable cervical CSF concentrations of the drug [12] . A greater degree of rostral spread for fentanyl than for bupivacaine could therefore explain this finding. Pain at rest was similar to pain on coughing within the bupivacaine only group whereas it was lower at rest than on coughing in the fentanyl groups. This could be explained by the same mechanism.
This study has demonstrated an additive analgesic effect between extradural 0.05 % bupivacaine and fentanyl, but it failed to demonstrate any clinical benefit from using the drugs in combination compared with fentanyl alone. Our patients undergoing Caesarean section are mobilized routinely on the first morning after operation and bupivacaine-related side effects that occurred with very low-dose bupivacaine inhibited this process. For postoperative patients where early ambulation is not routine, the improvement in analgesia that can be achieved by adding bupivacaine to fentanyl is more likely to contribute to an overall clinical benefit.
